Huperzine A: An Update on the Psychopharmacology of a Putative Disease-Modifying Alkaloid of Interest in Alzheimer’s Disease and Other Neurological Conditions

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Unknown venue

• Publication date

  2013-01-10

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1201/B13736-20
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• A phase II trial of huperzine A in mild to moderate Alzheimer disease

  2011cited by this paper
• SYNTHESIS AND PROPERTIES OF SULFUR-HETEROCYCLIC-BRIDGEDPOLYIMIDES WITH HIGH REFRACTIVE INDEX: SYNTHESIS AND PROPERTIES OF SULFUR-HETEROCYCLIC-BRIDGEDPOLYIMIDES WITH HIGH REFRACTIVE INDEX

  2009cited by this paper
• Role of Huperzine a in the Treatment of Alzheimer's Disease

  2009cited by this paper
• Efficacy and safety of natural acetylcholinesterase inhibitor huperzine A in the treatment of Alzheimer’s disease: an updated meta-analysis

  2009cited by this paper
• An update on huperzine A as a treatment for Alzheimer's disease

  2008cited by this paper
• Alternative Medicine and Alzheimer Disease

  2008cited by this paper
• Non-cholinergic Effects of Huperzine A: Beyond Inhibition of Acetylcholinesterase

  2008cited by this paper
• Huperzine A from Huperzia species--an ethnopharmacolgical review.

  2007cited by this paper
• Kinetic analysis of the protection afforded by reversible inhibitors against irreversible inhibition of acetylcholinesterase by highly toxic organophosphorus compounds.

  2006cited by this paper
• Cerebral changes on MRI and cognitive function: the CASCADE study.

  2006cited by this paper
• Effects of huperzine A on amyloid precursor protein processing and β‐amyloid generation in human embryonic kidney 293 APP Swedish mutant cells

  2006cited by this paper
• Comparative studies of huperzine A, donepezil, and rivastigmine on brain acetylcholine, dopamine, norepinephrine, and 5-hydroxytryptamine levels in freely-moving rats

  2006cited by this paper
• Pharmacological Profile of Huperzine A, a Novel Acetylcholinesterase Inhibitor from Chinese Herb

  2006cited by this paper
• Molecular dynamics simulations of interaction between protein-tyrosine phosphatase 1B and a bidentate inhibitor

  2006cited by this paper
• Current pharmacotherapy for Alzheimer's disease.

  2006cited by this paper
• Oral administration of pyridostigmine bromide and huperzine A protects human whole blood cholinesterases from ex vivo exposure to soman.

  2005cited by this paper
• Effects of huperzine A on secretion of nerve growth factor in cultured rat cortical astrocytes and neurite outgrowth in rat PC12 cells

  2005cited by this paper
• The Lycopodium alkaloids.

  2004cited by this paper
• Cholinesterase inhibitors: new roles and therapeutic alternatives.

  2004cited by this paper
• Acute effects of huperzine A and tacrine on rat liver.

  2003cited by this paper
• The psychopharmacology of huperzine A: an alkaloid with cognitive enhancing and neuroprotective properties of interest in the treatment of Alzheimer's disease.

  2003cited by this paper
• SUBCHRONIC ADMINISTRATION OF PYRIDOSTIGMINE OR HUPERZINE TO PRIMATES: COMPARED EFFICACY AGAINST SOMAN TOXICITY

  2002cited by this paper
• Review of the value of huperzine as pretreatment of organophosphate poisoning.

  2002cited by this paper
• AF150(S) and AF267B

  2002cited by this paper
• Potentiation of Nerve Growth Factor-Induced Neurite Outgrowth in PC12 Cells by a Coptidis Rhizoma Extract and Protoberberine Alkaloids

  2002cited by this paper
• Interaction of a new potent anticholinesterasic compound (+/-)huprine X with muscarinic receptors in rat brain.

  2002cited by this paper
• Huperzine A attenuates cognitive deficits and brain injury in neonatal rats after hypoxia-ischemia.

  2002cited by this paper
• [Clinical efficacy and safety of huperzine Alpha in treatment of mild to moderate Alzheimer disease, a placebo-controlled, double-blind, randomized trial].

  2002cited by this paper
• Huperzine A protects rat pheochromocytoma cells against oxygen–glucose deprivation

  2001cited by this paper
• Synthesis and acetylcholinesterase inhibition of 5-desamino huperzine A derivatives.

  2001cited by this paper
• Effect of huperzine A on working memory in reserpine- or yohimbine-treated monkeys.

  2001cited by this paper
• Huperzine B, a novel acetylcholinesterase inhibitor, attenuates hydrogen peroxide induced injury in PC12 cells.

  2000cited by this paper
• Huperzine A, a potential therapeutic agent for treatment of Alzheimer's disease.

  2000cited by this paper
• Galantamine

  2000cited by this paper
• Huperzine A reverses scopolamine- and muscimol-induced memory deficits in chick.

  2000cited by this paper
• [Huperzine a: an acetylcholinesterase inhibitor with high pharmacological potential].

  1999cited by this paper
• Huperzine-A in capsules and tablets for treating patients with Alzheimer disease.

  1999cited by this paper
• Improving effects of huperzine A on spatial working memory in aged monkeys and young adult monkeys with experimental cognitive impairment.

  1999cited by this paper
• Ginkgolide A, B, and huperzine A inhibit nitric oxide production from rat C6 and human BT325 glioma cells.

  1999cited by this paper
• Huperzine-A capsules enhance memory and learning performance in 34 pairs of matched adolescent students.

  1999cited by this paper
• Suppressive action produced by β-amyloid peptide fragment 31–35 on long-term potentiation in rat hippocampus is N-methyl-d-aspartate receptor-independent: it's offset by (−)huperzine A

  1999cited by this paper
• Improving effects of huperzine A on abnormal lipid peroxidation and superoxide dismutase in aged rats.

  1999cited by this paper
• Synthesis and biological activity of an optically pure 10-spirocyclopropyl analog of huperzine A

  1998cited by this paper
• Effects of huperzine A on nucleus basalis magnocellularis lesion-induced spatial working memory deficit.

  1998cited by this paper
• Effects of synthetic (-)-huperzine A on cholinesterase activities and mouse water maze performance.

  1998cited by this paper
• Double‐blind Trial of Aniracetam on Cognitive Deterioration in 622 Cases of Benign Senescent Forgetfulness, Vascular Dementia, and Alzheimer's Disease

  1998cited by this paper
• Reversal of scopolamine-induced deficits in radial maze performance by (-)-huperzine A: comparison with E2020 and tacrine.

  1998cited by this paper
• An analysis of low level doses of cholinesterase inhibitors in cultured neurons and hippocampal slices of rats.

  1998cited by this paper
• Anticholinesterase effects of huperzine A, E2020, and tacrine in rats.

  1998cited by this paper
• Comparative studies of huperzine A, E2020, and tacrine on behavior and cholinesterase activities.

  1998cited by this paper
• Structure of acetylcholinesterase complexed with the nootropic alkaloid, (–)-huperzine A

  1997cited by this paper
• Huperzine A, a potential therapeutic agent for dementia, reduces neuronal cell death caused by glutamate

  1997cited by this paper
• Efficacy of huperzine in preventing soman‐induced seizures, neuropathological changes and lethality

  1997cited by this paper
• Second generation cholinesterase inhibitors: Effect of (L)‐huperzine‐A on cortical biogenic amines

  1995cited by this paper
• Effect of huperzine A, a novel acetylcholinesterase inhibitor, on radial maze performance in rats.

  1995cited by this paper
• Efficacy of tablet huperzine-A on memory, cognition, and behavior in Alzheimer's disease.

  1995cited by this paper
• Huperzine A as a pretreatment candidate drug against nerve agent toxicity.

  1994cited by this paper
• Identification of amino acid residues involved in the binding of Huperzine A to cholinesterases

  1994cited by this paper
• Comparison of the effects of natural and synthetic huperzine-A on rat brain cholinergic function in vitro and in vivo.

  1994cited by this paper
• Cognition Improvement by Oral Huperzine A: A Novel Acetylcholinesterase Inhibitor

  1994cited by this paper
• Natural and Synthetic Huperzine A: Effect on Cholinergic Function in Vitro and in Vivo a

  1993cited by this paper
• The relationship of cerebrospinal fluid monoamine metabolites with clinical response to tetrahydroaminoacridine in patients with Alzheimer's disease

  1993cited by this paper
• Mechanism of inhibition of cholinesterases by huperzine A.

  1992cited by this paper
• [Drug evaluation of huperzine A in the treatment of senile memory disorders].

  1991cited by this paper
• Acute and chronic studies with the anticholinesterase Huperzine A: effect on central nervous system cholinergic parameters.

  1991cited by this paper
• The role of interactions between the cholinergic system and other neuromodulatory systems in learing and memory

  1991cited by this paper
• Huperzine A--a potent acetylcholinesterase inhibitor of use in the treatment of Alzheimer's disease.

  1991cited by this paper
• A total synthesis of (±)-huperzine A

  1989cited by this paper
• Effect of huperzine A, a new cholinesterase inhibitor, on the central cholinergic system of the rat

  1989cited by this paper
• The effect of heptyl-physostigmine, a new cholinesterase inhibitor, on the central cholinergic system of the rat

  1989cited by this paper
• A practical synthesis of the Chinese "nootropic" agent huperzine A: a possible lead in the treatment of Alzheimer's disease

  1989cited by this paper
• [Improvement of impaired memory in mice by huperzine A and huperzine B].

  1988cited by this paper
• [Cholinesterase inhibition by huperzine B].

  1987cited by this paper
• [Effects of huperzine A and B on skeletal muscle and the electroencephalogram].

  1987cited by this paper
• The structures of huperzine A and B, two new alkaloids exhibiting marked anticholinesterase activity

  1986cited by this paper
• [Anti-cholinesterase activity of huperzine A].

  1986cited by this paper
• Biochemical Assessment of Serotonergic and Cholinergic Dysfunction and Cerebral Atrophy in Alzheimer's Disease

  1983cited by this paper
• CHANGES IN BRAIN CHOLINESTERASES IN SENILE DEMENTIA OF ALZHEIMER TYPE

  1978cited by this paper

• No citing papers are available for this paper.